Artificial intelligence (AI) in mammographic screening in Norway BreastScreen Norway discusses how the results from their screening programme for early breast cancer detection can influence future artificial intelligence to streamline early breast cancer detection. Breast cancer is a significant global health concern, with more than 2 million new cases diagnosed and over half a million women dying from the disease annually.(1) Many countries, including Norway, have implemented mammographic screening to detect breast cancer in an early stage of disease development, as an early intervention has clear benefits on the disease outcome. In Norway, all women aged 50 to 69 years are invited to biennial mammographic screening through the national screening program, BreastScreen Norway.(2)
No takes yet. Share an insight, caveat, or question.
Holen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: